Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

News Features

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

Yael L. Maxwell

March 27, 2025

News Daily News

Going Contrast Free in TAVI Is Safe for CKD Patients

Caitlin E. Cox

August 20, 2024

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Conference News TCT 2023

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

Todd Neale

October 26, 2023

News Conference News CRT 2021

Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows

Michael O'Riordan

March 09, 2021

News Conference News PCR London Valves 2020

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Shelley Wood

November 26, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Daily News

Which Modality and When? New Guidance for Cardiac Imaging in COVID-19

Shelley Wood

July 24, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

Todd Neale

February 05, 2020

News Conference News PCR London Valves 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News ESC 2018

Cardiac CTA Radiation Dose Has Dropped by Nearly 80% Over the Last Decade

L.A. McKeown

September 06, 2018

$A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years$

News Daily News

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Yael L. Maxwell

August 10, 2018

Advertisement

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

Going Contrast Free in TAVI Is Safe for CKD Patients

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Which TAVR Device Is Best? Review Tackles Optimal Selection

Which Modality and When? New Guidance for Cardiac Imaging in COVID-19

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

ACS After TAVR a Unique Condition With Poor Prognosis

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Cardiac CTA Radiation Dose Has Dropped by Nearly 80% Over the Last Decade

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content